Copyright Reports & Markets. All rights reserved.

Global Oncology Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Oncology Drug

      • 1.1 Definition of Oncology Drug
      • 1.2 Oncology Drug Segment by Type
        • 1.2.1 Global Oncology Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Chemotherapy
        • 1.2.3 Targeted Therapy
        • 1.2.4 Immunotherapy
        • 1.2.5 Hormonal Therapy
        • 1.2.6 Others
      • 1.3 Oncology Drug Segment by Applications
        • 1.3.1 Global Oncology Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Blood Cancer
        • 1.3.3 Breast Cancer
        • 1.3.4 gastrointestinal Tract Cancer
        • 1.3.5 Prostate Cancer
        • 1.3.6 Lung Cancer
        • 1.3.7 Skin Cancer
      • 1.4 Global Oncology Drug Overall Market
        • 1.4.1 Global Oncology Drug Revenue (2014-2025)
        • 1.4.2 Global Oncology Drug Production (2014-2025)
        • 1.4.3 North America Oncology Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Oncology Drug Status and Prospect (2014-2025)
        • 1.4.5 China Oncology Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Oncology Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Oncology Drug Status and Prospect (2014-2025)
        • 1.4.8 India Oncology Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Oncology Drug
      • 2.3 Manufacturing Process Analysis of Oncology Drug
      • 2.4 Industry Chain Structure of Oncology Drug

      3 Development and Manufacturing Plants Analysis of Oncology Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Oncology Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Oncology Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Oncology Drug Production and Capacity Analysis
      • 4.2 Oncology Drug Revenue Analysis
      • 4.3 Oncology Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Oncology Drug Regional Market Analysis

      • 5.1 Oncology Drug Production by Regions
        • 5.1.1 Global Oncology Drug Production by Regions
        • 5.1.2 Global Oncology Drug Revenue by Regions
      • 5.2 Oncology Drug Consumption by Regions
      • 5.3 North America Oncology Drug Market Analysis
        • 5.3.1 North America Oncology Drug Production
        • 5.3.2 North America Oncology Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Oncology Drug Import and Export
      • 5.4 Europe Oncology Drug Market Analysis
        • 5.4.1 Europe Oncology Drug Production
        • 5.4.2 Europe Oncology Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Oncology Drug Import and Export
      • 5.5 China Oncology Drug Market Analysis
        • 5.5.1 China Oncology Drug Production
        • 5.5.2 China Oncology Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Oncology Drug Import and Export
      • 5.6 Japan Oncology Drug Market Analysis
        • 5.6.1 Japan Oncology Drug Production
        • 5.6.2 Japan Oncology Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Oncology Drug Import and Export
      • 5.7 Southeast Asia Oncology Drug Market Analysis
        • 5.7.1 Southeast Asia Oncology Drug Production
        • 5.7.2 Southeast Asia Oncology Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Oncology Drug Import and Export
      • 5.8 India Oncology Drug Market Analysis
        • 5.8.1 India Oncology Drug Production
        • 5.8.2 India Oncology Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Oncology Drug Import and Export

      6 Oncology Drug Segment Market Analysis (by Type)

      • 6.1 Global Oncology Drug Production by Type
      • 6.2 Global Oncology Drug Revenue by Type
      • 6.3 Oncology Drug Price by Type

      7 Oncology Drug Segment Market Analysis (by Application)

      • 7.1 Global Oncology Drug Consumption by Application
      • 7.2 Global Oncology Drug Consumption Market Share by Application (2014-2019)

      8 Oncology Drug Major Manufacturers Analysis

      • 8.1 Roche Ltd
        • 8.1.1 Roche Ltd Oncology Drug Production Sites and Area Served
        • 8.1.2 Roche Ltd Product Introduction, Application and Specification
        • 8.1.3 Roche Ltd Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis AG
        • 8.2.1 Novartis AG Oncology Drug Production Sites and Area Served
        • 8.2.2 Novartis AG Product Introduction, Application and Specification
        • 8.2.3 Novartis AG Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Bristol-Myers Squibb
        • 8.3.1 Bristol-Myers Squibb Oncology Drug Production Sites and Area Served
        • 8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.3.3 Bristol-Myers Squibb Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Celgene Corporation
        • 8.4.1 Celgene Corporation Oncology Drug Production Sites and Area Served
        • 8.4.2 Celgene Corporation Product Introduction, Application and Specification
        • 8.4.3 Celgene Corporation Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Johnson & Johnson
        • 8.5.1 Johnson & Johnson Oncology Drug Production Sites and Area Served
        • 8.5.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.5.3 Johnson & Johnson Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Pfizer Inc.
        • 8.6.1 Pfizer Inc. Oncology Drug Production Sites and Area Served
        • 8.6.2 Pfizer Inc. Product Introduction, Application and Specification
        • 8.6.3 Pfizer Inc. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Astra Zenca Plc
        • 8.7.1 Astra Zenca Plc Oncology Drug Production Sites and Area Served
        • 8.7.2 Astra Zenca Plc Product Introduction, Application and Specification
        • 8.7.3 Astra Zenca Plc Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Eli Lilly And Company.
        • 8.8.1 Eli Lilly And Company. Oncology Drug Production Sites and Area Served
        • 8.8.2 Eli Lilly And Company. Product Introduction, Application and Specification
        • 8.8.3 Eli Lilly And Company. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Glaxosmithkline Plc
        • 8.9.1 Glaxosmithkline Plc Oncology Drug Production Sites and Area Served
        • 8.9.2 Glaxosmithkline Plc Product Introduction, Application and Specification
        • 8.9.3 Glaxosmithkline Plc Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Merck & Co.
        • 8.10.1 Merck & Co. Oncology Drug Production Sites and Area Served
        • 8.10.2 Merck & Co. Product Introduction, Application and Specification
        • 8.10.3 Merck & Co. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Sanofi
      • 8.12 Amgen Inc.
      • 8.13 Abbvie

      9 Development Trend of Analysis of Oncology Drug Market

      • 9.1 Global Oncology Drug Market Trend Analysis
        • 9.1.1 Global Oncology Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Oncology Drug Regional Market Trend
        • 9.2.1 North America Oncology Drug Forecast 2019-2025
        • 9.2.2 Europe Oncology Drug Forecast 2019-2025
        • 9.2.3 China Oncology Drug Forecast 2019-2025
        • 9.2.4 Japan Oncology Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Oncology Drug Forecast 2019-2025
        • 9.2.6 India Oncology Drug Forecast 2019-2025
      • 9.3 Oncology Drug Market Trend (Product Type)
      • 9.4 Oncology Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Oncology Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Drugs used for oncology.

        The global Oncology Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Oncology Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Oncology Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Oncology Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Roche Ltd
        Novartis AG
        Bristol-Myers Squibb
        Celgene Corporation
        Johnson & Johnson
        Pfizer Inc.
        Astra Zenca Plc
        Eli Lilly And Company.
        Glaxosmithkline Plc
        Merck & Co.
        Sanofi
        Amgen Inc.
        Abbvie

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Chemotherapy
        Targeted Therapy
        Immunotherapy
        Hormonal Therapy
        Others

        Segment by Application
        Blood Cancer
        Breast Cancer
        gastrointestinal Tract Cancer
        Prostate Cancer
        Lung Cancer
        Skin Cancer

        Buy now